Scott Eric Plevy

UNCCH, School of Medicine, Medicine

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Patents
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network
• Curriculum Vitae

Scott Eric Plevy

• Organizations
  University of North Carolina at Chapel Hill
  
  School of Medicine
  
  Medicine
  
  

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Iris Dotan; Scott Eric Plevy

  NOD2 and pouch complications in UC patients: Old-world clinical dogmas give way to biological definitions

  Gut. 2013.
  0

• 2.

  2013

  Dongyun Liu; Taku Kobayashi; Steven Russo; Fengling Li; Scott E. Plevy; Todd M. Gambling; Johnny L. Carson; Russell J. Mumper

  In vitro and in vivo evaluation of a water-in-oil microemulsion system for enhanced peptide intestinal delivery

  AAPS Journal. 2013;15(1):288-298.
  0

• 3.

  2013

  K.M. Gowdy; D.M. Cardona; J.L. Nugent; C. Giamberardino; J.M. Thomas; S. Mukherjee; T. Martinu; W.M. Foster; S.E. Plevy; A.M. Pastva; et al.

  Erratum: Novel role for surfactant protein A in gastrointestinal graft-versus-host disease (The Journal of Immunology (2012) 188 (4897-4905))

  Journal of Immunology. 2013;190(3):1382.
  0

• 4.

  2013

  Joseph C. Onyiah; Shehzad Z. Sheikh; Nitsan Maharshak; Erin C. Steinbach; Steven M. Russo; Taku Kobayashi; Lantz C. Mackey; Jonathan J. Hansen; Adam J. Moeser; John F. Rawls; et al.

  Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance

  Gastroenterology. 2013;144(4):789-798.
  0

• 5.

  2013

  W.J. Sandborn; J.-F. Colombel; G. D'Haens; S.E. Plevy; J. Panés; A.M. Robinson; P.F. Pollack; Q. Zhou; M. Castillo; R.B. Thakkar

  Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's disease

  Current Medical Research and Opinion. 2013;29(5):483-493.
  0

• 6.

  2013

  E.M. Lennon; Nitsan Maharshak; H. Elloumi; L. Borst; S.E. Plevy; Adam J. Moeser

  Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10^-/- Mice

  Inflammatory Bowel Diseases. 2013;19(4):712-719.
  0

• 7.

  2013

  Shinichiro Shinzaki; Eri Kuroki; Hideki Iijima; Norika Tatsunaka; Mayuko Ishii; Hironobu Fujii; Yoshihiro Kamada; Taku Kobayashi; Narihiro Shibukawa; Takahiro Inoue; et al.

  Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease

  Inflammatory Bowel Diseases. 2013;19(2):321-331.
  0

• 8.

  2013

  Lee A. Denson; Millie D. Long; Dermot P. B. McGovern; Subra Kugathasan; Gary D. Wu; Vincent B. Young; Theresa T. Pizarro; Edwin F. De Zoeten; Thaddeus S. Stappenbeck; Scott E. Plevy; et al.

  Challenges in IBD research: Update on progress and prioritization of the CCFA's research agenda

  Inflammatory Bowel Diseases. 2013;19(4):677-682.
  0

• 9.

  2012

  Houda Z. Elloumi; Nitsan Maharshak; Kavitha N. Rao; Taku Kobayashi; Hyungjin S. Ryu; Marcus Mühlbauer; Fengling Li; Christian Jobin; Scott E. Plevy

  A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis

  PLoS ONE. 2012;7(3).
  1

• 10.

  2012

  Kymberly M. Gowdy; Diana M. Cardona; Julia L. Nugent; Charles Giamberardino; Joseph M. Thomas; Sambudho Mukherjee; Tereza Martinu; W. Michael Foster; Scott E. Plevy; Amy M. Pastva; et al.

  Novel role for surfactant protein A in gastrointestinal graft-versus-host disease

  Journal of Immunology. 2012;188(10):4897-4905.
  1

• 11.

  2012

  Taku Kobayashi; Katsuyoshi Matsuoka; Shehzad Z. Sheikh; Steven M. Russo; Yoshiyuki Mishima; Colm Collins; Edwin F. DeZoeten; Christopher L. Karp; Jenny P. Y. Ting; R. Balfour Sartor; et al.

  IL-10 regulates Il12b expression via histone deacetylation: Implications for intestinal macrophage homeostasis

  Journal of Immunology. 2012;189(4):1792-1799.
  2

• 12.

  2012

  Eda K. Holl; Kelly E. Roney; Irving C. Allen; Erin Steinbach; Janelle C. Arthur; Adam Buntzman; Scott Plevy; Jeffrey Frelinger; Jenny P.-Y. Ting

  Plexin-B2 and Plexin-D1 in dendritic cells: Expression and IL-12/IL-23p40 production

  PLoS ONE. 2012;7(8).
  3

• 13.

  2012

  Satoshi Serada; Minoru Fujimoto; Fumitaka Terabe; Hideki Iijima; Shinichiro Shinzaki; Shinya Matsuzaki; Tomoharu Ohkawara; Riichiro Nezu; Sachiko Nakajima; Taku Kobayashi; et al.

  Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis

  Inflammatory Bowel Diseases. 2012;18(11):2169-2179.
  1

• 14.

  2011

  William J. Sandborn; Jean-Frédéric Colombel; Stefan Schreiber; Scott E. Plevy; Paul F. Pollack; Anne M. Robinson; Jingdong Chao; Parvez Mulani

  Dosage adjustment during long-term adalimumab treatment for Crohn's disease: Clinical efficacy and pharmacoeconomics

  Inflammatory Bowel Diseases. 2011;17(1):141-151.
  15

• 15.

  2011

  Shehzad Z. Sheikh; Taku Kobayashi; Katsuyoshi Matsuoka; Joseph C. Onyiah; Scott E. Plevy

  Characterization of an Interferon-stimulated Response Element (ISRE) in the Il23a promoter

  Journal of Biological Chemistry. 2011;286(2):1174-1180.
  5

• 16.

  2011

  Geert R. D'Haens; Remo Panaccione; Peter D.R. Higgins; Severine Vermeire; Miquel Gassull; Yehuda Chowers; Stephen B. Hanauer; Hans Herfarth; Daan W. Hommes; Michael Kamm; et al.

  The London position statement of the World Congress of gastroenterology on biological therapy for IBD with the European Crohn's and Colitis Organization: When to start, when to stop, which drug to choose, and how to predict response

  American Journal of Gastroenterology. 2011;106(2):199-212.
  63

• 17.

  2011

  Geert R. D'Haens; Remo Panaccione; Peter D. R. Higgins; Severine Vermeire; Miquel Gassull; Yehuda Chowers; Stephen B. Hanauer; Hans Herfarth; Daan W. Hommes; Michael Kamm; et al.

  Erratum: The London position statement of the world congress of gastroenterology on biological therapy for IBD with the European crohn's and colitis organization: When to start, when to stop, which drug to choose, and how to predict response (American Journal of Gastroenterology (2010) 105 (2551-2561) DOI: 10.1038/ ajg.2010.372)

  American Journal of Gastroenterology. 2011;106(2):375.
  0

• 18.

  2011

  Shehzad Z. Sheikh; Jennifer Uno; Katsuyoshi Matsuoka; Scott E. Plevy

  Reply to L. Xue and Q. Ouyang, "Diagnostic criteria of inflammatory bowel disease"

  Clinical Immunology. 2011;139(1):104.
  0

• 19.

  2011

  Taku Kobayashi; Katsuyoshi Matsuoka; Shehzad Z. Sheikh; Houda Z. Elloumi; Nobuhiko Kamada; Tadakazu Hisamatsu; Jonathan J. Hansen; Kevin R. Doty; Scott D. Pope; Stephen T. Smale; et al.

  NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunity

  Journal of Immunology. 2011;186(8):4649-4655.
  13

• 20.

  2011

  Shehzad Z. Sheikh; Refaat A. Hegazi; Taku Kobayashi; Joseph C. Onyiah; Steven M. Russo; Katsuyoshi Matsuoka; Antonia R. Sepulveda; Fengling Li; Leo E. Otterbein; Scott E. Plevy

  An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis

  Journal of Immunology. 2011;186(9):5506-5513.
  18

• 21.

  2011

  Scott E. Plevy; Stephan R. Targan

  Future therapeutic approaches for inflammatory bowel diseases

  Gastroenterology. 2011;140(6):1838-1846.
  19

• 22.

  2011

  Nitsan Maharshak; Scott E. Plevy

  A Crohn's disease patient who does not respond to infliximab: What is next?

  Clinical Gastroenterology and Hepatology. 2011;9(12):1033-1038.
  2

• 23.

  2010

  Melanie A. Ruffner; Scott E. Plevy; Anthony T. Cheung

  Gene therapy for the treatment of inflammatory bowel disease

  Milestones in Drug Therapy. 2010:19-37.
  0

• 24.

  2010

  Rekha R. Rapaka; David M. Ricks; John F. Alcorn; Kong Chen; Shabaana A. Khader; Mingquan Zheng; Scott Plevy; Eva Bengtén; Jay K. Kolls

  Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina

  Journal of Experimental Medicine. 2010;207(13):2907-2919.
  17

• 25.

  2010

  Daniel C. Baumgart; Stephan R. Targan; Axel U. Dignass; Lloyd Mayer; Gert Van Assche; Daan W. Hommes; Stephen B. Hanauer; Uma Mahadevan; Walter Reinisch; et al.

  Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis

  Inflammatory Bowel Diseases. 2010;16(4):620-629.
  24

• 26.

  2010

  Shehzad Z. Sheikh; Katsuyoshi Matsuoka; Taku Kobayashi; Fengling Li; Tara Rubinas; Scott E. Plevy

  Cutting edge: IFN-γ is a negative regulator of IL-23 in murine macrophages and experimental colitis

  Journal of Immunology. 2010;184(8):4069-4073.
  19

• 27.

  2010

  Patcharica Meteesatien; Scott E. Plevy; Justin D. Fender; Yuri Fedoriw

  Circulating blasts in a Crohn's patient treated with natalizumab

  Laboratory Medicine. 2010;41(8):453-456.
  0

• 28.

  2010

  Holden T. Maecker; J Philip McCoy; Michael Amos; John Elliott; Adolfas Gaigalas; Lili Wang; Richard Aranda; Jacques Banchereau; Chris Boshoff; Jonathan Braun; et al.

  A model for harmonizing flow cytometry in clinical trials

  Nature Immunology. 2010;11(11):975-978.
  22

• 29.

  2010

  Shehzad Z Sheikh; Scott E Plevy

  The role of the macrophage in sentinel responses in intestinal immunity

  Current Opinion in Gastroenterology. 2010;26(6):578-582.
  9

• 30.

  2010

  Jennifer K. Uno; Kavitha N. Rao; Katsuyoshi Matsuoka; Shehzad Z. Sheikh; Taku Kobayashi; Fengling Li; Erin C. Steinbach; Antonia R. Sepulveda; Bart Vanhaesebroeck; R. Balfour Sartor; et al.

  Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110δ

  Gastroenterology. 2010;139(5):1642-1653.e6.
  8

• 31.

  2010

  William J. Sandborn; Jean Frederic Colombel; Matthew Frankel; Daan Hommes; James N. Lowder; Lloyd Mayer; Scott Plevy; Pieter Stokkers; Simon Travis; Gert Van Assche; et al.

  Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis

  Gut. 2010;59(11):1485-1492.
  24

• 32.

  2009

  Miguel Regueiro; Wolfgang Schraut; Leonard Baidoo; Kevin E. Kip; Antonia R. Sepulveda; Marilyn Pesci; Janet Harrison; Scott E. Plevy

  Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection

  Gastroenterology. 2009;136(2):441-450.e1.
  170

• 33.

  2009

  Xiaonan Han; Kanji Uchida; Ingrid Jurickova; Diana Koch; Tara Willson; Charles Samson; Erin Bonkowski; Anna Trauernicht; Mi-Ok Kim; Gitit Tomer; et al.

  Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Murine Ileitis and Progressive Ileal Crohn's Disease

  Gastroenterology. 2009;136(4):1261-1271.e3.
  19

• 34.

  2009

  Millie D. Long; Scott E. Plevy

  Poorly Responsive Ulcerative Colitis in the Hospital

  Clinical Gastroenterology and Hepatology. 2009;7(6):635-640.
  0

• 35.

  2009

  Scott E. Plevy

  Investigating the role of autophagy in the pathophysiology of IBD

  Gastroenterology and Hepatology. 2009;5(6):407-409.
  0

• 36.

  2009

  Stephen B. Hanauer; Scott E. Plevy; Bruce E. Sands; Stephan R. Targan

  Therapeutic targets for emerging biologic therapies in IBD

  Gastroenterology and Hepatology. 2009;5(7 SUPPL. 16):4-15.
  0

• 37.

  2009

  Shaival H. Davé; Jeremy S. Tilstra; Katsuyoshi Matsuoka; Fengling Li; Richard A. DeMarco; Donna Beer-Stolz; Antonia R. Sepulveda; Mitchell P. Fink; Michael T. Lotze; Scott E. Plevy

  Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis

  Journal of Leukocyte Biology. 2009;86(3):633-643.
  29

• 38.

  2008

  L. Campbell Levy; Scott E. Plevy

  Farm Animals and Inflammatory Bowel Disease: Old MacDonald Had Poor Hygiene

  Gastroenterology. 2008;134(3):886-887.
  0

• 39.

  2008

  Shehzad Sheikh; Jennifer Uno; Katsuyoshi Matsuoka; Scott Plevy

  Abnormal mucosal immune response to altered bacterial flora following restorative proctocolectomy in patients with ulcerative colitis: Serologic measures, immunogenetics, and clinical correlations

  Clinical Immunology. 2008;127(3):270-279.
  3

• 40.

  2007

  Milena Bogunovic; Shaival H. Davé; Jeremy S. Tilstra; Diane T. W. Chang; Noam Harpaz; Huabao Xiong; Lloyd F. Mayer; Scott E. Plevy

  Enteroendocrine cells express functional Toll-like receptors

  American Journal of Physiology - Gastrointestinal and Liver Physiology. 2007;292(6):G1770-G1783.
  39

• 41.

  2007

  J. Tilstra; K.K. Rehman; T. Hennon; S.E. Plevy; P. Clemens; P.D. Robbins

  Protein transduction: Identification, characterization and optimization

  Biochemical Society Transactions. 2007;35(4):811-815.
  25

• 42.

  2007

  Miguel Regueiro; Benjamin Siemanowski; Kevin E. Kip; Scott Plevy

  Infliximab dose intensification in Crohn's disease

  Inflammatory Bowel Diseases. 2007;13(9):1093-1099.
  58

• 43.

  2007

  Pamela L. Beatty; Scott E. Plevy; Antonia R. Sepulveda; Olivera J. Finn

  Cutting edge: Transgenic expression of human MUC1 in IL-10^-/- mice accelerates inflammatory bowel disease and progression to colon cancer

  Journal of Immunology. 2007;179(2):735-739.
  31

• 44.

  2007

  Scott E. Plevy

  Optimizing the use of biologic therapies in the treatment of inflammatory bowel disease

  Gastroenterology and Hepatology. 2007;3(8):592-594.
  0

• 45.

  2007

  Scott Plevy; Bruce Salzberg; Gert Van Assche; Miguel Regueiro; Daniel Hommes; William Sandborn; Stephen Hanauer; Stephan Targan; Lloyd Mayer; Uma Mahadevan; et al.

  A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis

  Gastroenterology. 2007;133(5):1414-1422.
  69

• 46.

  2007

  Carmen Meier; Scott Plevy

  Therapy insight: How the gut talks to the joints - Inflammatory bowel disease and the spondyloarthropathies

  Nature Clinical Practice Rheumatology. 2007;3(11):667-674.
  5

• 47.

  2007

  Katsuyoshi Matsuoka; Scott Plevy

  Salvation through death: Preaching the dogma of apoptosis

  Inflammatory Bowel Diseases. 2007;13(11):1446-1447.
  0

• 48.

  2007

  Maria T. Abreu; Scott Plevy; Bruce E. Sands; Robert Weinstein

  Selective leukocyte apheresis for the treatment of inflammatory bowel disease

  Journal of Clinical Gastroenterology. 2007;41(10):874-888.
  19

• 49.

  2007

  Stephen B. Hanauer; Sunanda V. Kane; Scott E. Plevy; Corey A. Siegel

  A case-based discussion on managing Crohn's disease: Integrating the new generation of anti-TNF-α therapies

  Gastroenterology and Hepatology. 2007;3(12 SUPPL. 35):3-13.
  0

• 50.

  2007

  Shaival H. Davé; Jeremy S. Tilstra; Katsuyoshi Matsuoka; Fengling Li; Thomas Karrasch; Jennifer K. Uno; Antonia R. Sepulveda; Christian Jobin; Albert S. Baldwin; et al.

  Amelioration of chronic murine colitis by peptide-mediated transduction of the IκB kinase inhibitor NEMO binding domain peptide

  Journal of Immunology. 2007;179(11):7852-7859.
  38

• 51.

  2006

  Miguel Regueiro; Jennifer Curtis; Scott Plevy

  Infliximab for hospitalized patients with severe ulcerative colitis

  Journal of Clinical Gastroenterology. 2006;40(6):476-481.
  37

• 52.

  2006

  Shehzad Sheikh; Scott Plevy

  Medical Management of Surgical Inflammatory Bowel Disease? Current Concepts and Future Possibilities

  Seminars in Colon and Rectal Surgery. 2006;17(2):50-54.
  0

• 53.

  2006

  Arthur Barrie; Scott Plevy

  Treatment of Immune-Mediated Extraintestinal Manifestations of Inflammatory Bowel Disease with Infliximab

  Gastroenterology Clinics of North America. 2006;35(4):883-893.
  14

• 54.

  2005

  Scott Plevy

  A STAT need for human immunologic studies to understand inflammatory bowel disease

  American Journal of Gastroenterology. 2005;100(1):73-74.
  5

• 55.

  2005

  Miguel Regueiro; Kevin E. Kip; Onki Cheung; Refaat A. Hegazi; Scott Plevy

  Cigarette smoking and age at diagnosis of inflammatory bowel disease

  Inflammatory Bowel Diseases. 2005;11(1):42-47.
  30

• 56.

  2005

  Marc C. Hochberg; Mark G. Lebwohl; Scott E. Plevy; Kathryn F. Hobbs; David E. Yocum

  The benefit/risk profile of TNF-blocking agents: Findings of a consensus panel

  Seminars in Arthritis and Rheumatism. 2005;34(6):819-836.
  126

• 57.

  2005

  Arthur M. Barrie III; Scott E. Plevy

  The interleukin-12 family of cytokines: Therapeutic targets for inflammatory disease mediation

  Clinical and Applied Immunology Reviews. 2005;5(4):225-240.
  10

• 58.

  2005

  Carmen B. Meier; Refaat A. Hegazi; James Aisenberg; Peter E. Legnani; Naris Nilubol; Gena M. Cobrin; Richard H. Duerr; Stephen R. Gorfine; Joel J. Bauer; David B. Sachar; et al.

  Innate immune receptor genetic polymorphisms in pouchitis: Is CARD15 a susceptibility factor?

  Inflammatory Bowel Diseases. 2005;11(11):965-971.
  39

• 59.

  2005

  Refaat A.F. Hegazi; Kavitha N. Rao; Aqila Mayle; Antonia R. Sepulveda; Leo E. Otterbein; Scott E. Plevy

  Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway

  Journal of Experimental Medicine. 2005;202(12):1703-1713.
  103

• 60.

  2004

  Hui Zhou; Huabao Xiong; Hongxing Li; Scott E. Plevy; Paul D. Walden; Massimo Sassaroli; Glenn D. Prestwich; Jay C. Unkelesss

  Microtubule-Associated Serine/Threonine Kinase-205 kDa and Fcγ Receptor Control IL-12 p40 Synthesis and NF-κB Activation

  Journal of Immunology. 2004;172(4):2559-2568.
  7

• 61.

  2004

  Georgios Papachristou; Scott Plevy

  Immunospecific Therapy in IBD: Rationale and Practical Application

  Practical Gastroenterology. 2004;28(1):18-30.
  0

• 62.

  2004

  Huabao Xiong; Chen Zhu; Fengling Li; Refaat Hegazi; Kaili He; Mark Babyatsky; Anthony J. Bauer; Scott E. Plevy

  Inhibition of Interleukin-12 p40 Transcription and NF-κB Activation by Nitric Oxide in Murine Macrophages and Dendritic Cells

  Journal of Biological Chemistry. 2004;279(11):10776-10783.
  44

• 63.

  2004

  Scott Plevy

  Do Serological Markers and Cytokines Determine the Indeterminate?

  Journal of Clinical Gastroenterology. 2004;38(5):S51-S56.
  15

• 64.

  2004

  William Hale; Martin Floch; Robert Burakoff; Steven Itzkowitz; Bryan Warren; Scott Plevy

  Indeterminate Colitis

  Journal of Clinical Gastroenterology. 2004;38(5):S57.
  1

• 65.

  2004

  Georgios I. Papachristou; Scott Plevy

  Novel biologics in inflammatory bowel disease

  Gastroenterology Clinics of North America. 2004;33(2):251-269.
  13

• 66.

  2004

  Georgios I. Papachristou; Tong Wu; Wallis Marsh; Scott E. Plevy

  Inflammatory pseudotumor of the liver associated with Crohn's disease

  Journal of Clinical Gastroenterology. 2004;38(9):818-822.
  16

• 67.

  2004

  James Aisenberg; Peter E. Legnani; Naris Nilubol; Gena M. Cobrin; Sharif H. Ellozy; Refaat A.F. Hegazi; Jessica Yager; Carol Bodian; Stephen R. Gorfine; Joel J. Bauer; et al.

  Are pANCA, ASCA, or Cytokine Gene Polymorphisms Associated with Pouchitis? Long-term Follow-up in 102 Ulcerative Colitis Patients

  American Journal of Gastroenterology. 2004;99(3):432-441.
  36

• 68.

  2003

  Scott Plevy; Lloyd Mayer

  Meeting summary: Signal transduction pathways in immune and inflammatory cells November 30-December 3, 2000, Amelia Island, Florida, U.S.A

  Inflammatory Bowel Diseases. 2003;9(1):28-33.
  2

• 69.

  2003

  Huabao Xiong; Chen Zhu; Hongxing Li; Frank Chen; Lloyd Mayer; Keiko Ozato; Jay C. Unkeless; Scott E. Plevy

  Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-γ-induced iNOS gene expression

  Journal of Biological Chemistry. 2003;278(4):2271-2277.
  39

• 70.

  2003

  Adam Cheifetz; Michelle Smedley; Sara Martin; Monica Reiter; Grace Leone; Lloyd Mayer; Scott Plevy

  The incidence and management of infusion reactions to infliximab: A large center experience

  American Journal of Gastroenterology. 2003;98(6):1315-1324.
  236

• 71.

  2003

  Miguel Regueiro; John Valentine; Scott Plevy; Mark R. Fleisher; Gary R. Lichtenstein

  Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease

  American Journal of Gastroenterology. 2003;98(8):1821-1826.
  122

• 72.

  2003

  Chen Zhu; Kavitha Rao; Huabao Xiong; Khatuna Gagnidze; Fengling Li; Curt Horvath; Scott Plevy

  Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP

  Journal of Biological Chemistry. 2003;278(41):39372-39382.
  60

• 73.

  2002

  Scott Plevy

  The immunology of inflammatory bowel disease

  Gastroenterology Clinics of North America. 2002;31(1):77-92.
  29

• 74.

  2002

  H. Xiong; T. Futamura; H. Jourdi; H. Zhou; N. Takei; M. Diverse-Pierluissi; S. Plevy; H. Nawa

  Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons

  Neuropharmacology. 2002;42(7):903-912.
  26

• 75.

  2002

  Scott E. Plevy

  Corticosteroid-sparing treatments in patients with Crohn's disease

  American Journal of Gastroenterology. 2002;97(7):1607-1617.
  22

• 76.

  2001

  Kent D. Taylor; Scott E. Plevy; Huiying Yang; Carol J. Landers; Mary J. Barry; Jerome I. Rotter; Stephan R. Targan

  ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

  Gastroenterology. 2001;120(6):1347-1355.
  125

• 77.

  2001

  H. Xiong; S. Plevy

  Case report: Crohn's disease of the mouse.

  Inflammatory bowel diseases. 2001;7(4):347-348.
  0

• 78.

  2001

  Chen Zhu; Khatuna Gagnidze; James H. M. Gemberling; Scott E. Plevy

  Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter: Demonstration of novel functional elements by a reductionist approach

  Journal of Biological Chemistry. 2001;276(21):18519-18528.
  53

• 79.

  2001

  F. Cornillie; D. Shealy; G. D'Haens; K. Geboes; G. Van Assche; J. Ceuppens; C. Wagner; T. Schaible; S.E. Plevy; S.R. Targan; et al.

  Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease

  Alimentary Pharmacology and Therapeutics. 2001;15(4):463-473.
  115

• 80.

  2000

  F. Anderson Rowe; John H. Walker; Loren C. Karp; Eric A. Vasiliauskas; Scott E. Plevy; Stephan R. Targan

  Long-term follow-up of Barrett's high-grade dysplasia

  American Journal of Gastroenterology. 2000;95(8):1888-1893.
  178

• 81.

  2000

  Hans D. Brightbill; Scott E. Plevy; Robert L. Modlin; Stephen T. Smale

  A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages

  Journal of Immunology. 2000;164(4):1940-1951.
  186

• 82.

  1999

  Katherine Facklis; Scott E. Plevy; Eric A. Vasiliauskas; Lori Kam; Kent Taylor; Stephan R. Targan; Phillip R. Fleshner

  Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch- specific complications

  Diseases of the Colon and Rectum. 1999;42(5):601-606.
  20

• 83.

  1999

  H. Yang; S.E. Plevy; K. Taylor; D. Tyan; N. Fischel-Ghodsian; C. McElree; S.R. Targan; J.I. Rotter

  Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses

  Gut. 1999;44(4):519-526.
  86

• 84.

  1999

  Amy S. Weinmann; Scott E. Plevy; Stephen T. Smale

  Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription

  Immunity. 1999;11(6):665-675.
  121

• 85.

  1999

  Hans D. Brightbill; Daniel H. Libraty; Stephan R. Krutzik; Ruey-Bing Yang; John T. Belisle; Joshua R. Bleharski; Michael Maitland; Michael V. Norgard; Scott E. Plevy; et al.

  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors

  Science. 1999;285(5428):732-736.
  1088

• 86.

  1997

  Scott E. Plevy; James H. M. Gemberling; Sang Hsu; Andrew J. Dorner; Stephen T. Smale

  Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: Evidence of functional synergy between C/EBP and Rel proteins

  Molecular and Cellular Biology. 1997;17(8):4572-4588.
  223

• 87.

  1997

  Scott E. Plevy; Carol J. Landers; John Prehn; Nelson M. Carramanzana; Richard L. Deem; David Shealy; Stephan R. Targan

  A Role for TNF-α and Mucosal T Helper-1 Cytokines in the Pathogenesis of Crohn's Disease

  Journal of Immunology. 1997;159(12):6276-6282.
  251

• 88.

  1997

  R.F. Compton; W.J. Sandborn; H. Yang; N.M. Lindor; W.J. Tremaine; M.D.P. Davis; A.A. Khalil; N.A. Tountas; D.B. Tyan; C.J. Landers; et al.

  A new syndrome of Crohn's disease and pachydermoperiostosis in a family

  Gastroenterology. 1997;112(1):241-249.
  14

• 89.

  1996

  E.A. Vasiliauskas; S.E. Plevy; C.J. Landers; S.W. Binder; D.M. Ferguson; H. Yang; J.I. Rotter; A. Vidrich; S.R. Targan

  Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup

  Gastroenterology. 1996;110(6):1810-1819.
  207

• 90.

  1996

  S.E. Plevy; S.R. Targan; H. Yang; D. Fernandez; J.I. Rotter; H. Toyoda

  Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6

  Gastroenterology. 1996;110(4):1053-1060.
  112

• 91.

  1995

  P.R. Fleshner; F. Michelassi; M. Rubin; S.B. Hanauer; S.E. Plevy; S.R. Targan

  Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin

  Diseases of the Colon and Rectum. 1995;38(12):1241-1245.
  47